Although definitive conclusions cannot be drawn due to the small sample size, this study showed associations between differentially significant gene expression and event-free survival in pediatric patients with DLBCL, in particular those expressing MYC above the median, and NT5E and CD34 genes below the median, who had a lower event-free survival. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.